Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice

• Sefika Ozcelik,

  Affiliations Institute of Pathology, University Hospital Basel, Basel, Switzerland, Department of Neurology, University Hospital Basel, Basel, Switzerland

  ⨯
• Graham Fraser,

  Affiliation MRC, Laboratory of Molecular Biology, Cambridge, United Kingdom

  ⨯
• Perrine Castets,

  Affiliations Department of Neurology, University Hospital Basel, Basel, Switzerland, Neuromuscular Research Centre, Department of Biomedicine, University Hospital Basel, Basel, Switzerland

  ⨯
• Véronique Schaeffer,

  Affiliation MRC, Laboratory of Molecular Biology, Cambridge, United Kingdom

  ⨯
• Zhiva Skachokova,

  Affiliations Institute of Pathology, University Hospital Basel, Basel, Switzerland, Department of Neurology, University Hospital Basel, Basel, Switzerland

  ⨯
• Karin Breu,

  Affiliations Institute of Pathology, University Hospital Basel, Basel, Switzerland, Department of Neurology, University Hospital Basel, Basel, Switzerland

  ⨯
• Florence Clavaguera,

  Affiliation Institute of Pathology, University Hospital Basel, Basel, Switzerland

  ⨯
• Michael Sinnreich,

  Affiliations Department of Neurology, University Hospital Basel, Basel, Switzerland, Neuromuscular Research Centre, Department of Biomedicine, University Hospital Basel, Basel, Switzerland

  ⨯
• Ludwig Kappos,

  Affiliation Department of Neurology, University Hospital Basel, Basel, Switzerland

  ⨯
• Michel Goedert,

  Affiliation MRC, Laboratory of Molecular Biology, Cambridge, United Kingdom

  ⨯
• Markus Tolnay,

  Affiliation Institute of Pathology, University Hospital Basel, Basel, Switzerland

  ⨯
• David Theo Winkler

  * E-mail: winklerd@uhbs.ch

  Affiliations Institute of Pathology, University Hospital Basel, Basel, Switzerland, Department of Neurology, University Hospital Basel, Basel, Switzerland

  ⨯